Anavex Life Sciences Corp (AVXL)

[Hosai]

Just to remind on Dr Sabbaghs background - "Dr. Sabbagh is a leading investigator of many prominent national Alzheimer’s prevention and treatment clinical trials. He serves on the editorial boards of the Journal of Alzheimer’s Disease and Alzheimer’s and Dementia: Translational Research & Clinical Interventions. He is the editor-in-chief of Neurology and Therapy. Dr. Sabbagh is a prolific author who has written and edited books on Alzheimer’s disease and has contributed to hundreds of medical and scientific articles."

In a sense he's arguably one of the number 1 thought leaders on AD. So it's clearly a big deal for him to say a few days ago- "Couple of drugs I'm very excited about" and then talk about Blarcamesine as one of them and also say "so people are kind of saying...we didn't know about this and so there are a few sleeper surprises coming up the ranks that could really change the world and not just make it a monopoly on the monoclonals."